4142:TPE
Adimmune Corp
16,80Â TWD
arrow_upward
+0,60%(+0,100) 1Â D
13. nov., 13:30:11 GMT+8 · TWD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for 4142 …
Ã…pne
16,85Â TWD
Høy
17,15Â TWD
Lav
16,75Â TWD
Markedsverdi
7,22Â mrd.
Snittvolum
1,13Â mill.
Volum
724,64k
52 u høy
22,50Â TWD
52Â u lav
15,65Â TWD
EPS
−0,34 TWD
Utestående aksjer
235,29Â mill.
Antall ansatte
564
Ã…pne
16,85Â TWD
Høy
17,15Â TWD
Lav
16,75Â TWD
Markedsverdi
7,22Â mrd.
Snittvolum
1,13Â mill.
Volum
724,64k
52 u høy
22,50Â TWD
52Â u lav
15,65Â TWD
EPS
−0,34 TWD
Utestående aksjer
235,29Â mill.
Antall ansatte
564
Nyhetssaker
Fra nettkilder og nyhetspartnere
Vietnam.vn
·
for 59 minutter siden
S&P 500 og Nasdaq avsluttet sine fire uker lange tapsrekke.
Crypto News
·
for 1 time siden
Bitcoin below $70K, Coinbase charter, NYSE | Weekly recap
Macau Business
·
for 54 minutter siden
Innovative Immunology Biotech Windward Bio Lists on Nasdaq
bloomingbit
·
for 49 minutter siden
Anthropic Nears Nasdaq Debut as Korean AI ETFs Prepare Inclusion Plans [Lee Su’s ETF Zoom In]
Profil
Adimmune Corporation is a Taiwanese pharmaceutical company engaged in the research, development, manufacturing, and sales of medicines and vaccines for both humans and animals. Its products are supplied to both local and international markets.
Founded in 1965 and headquartered in Tanzi District, Taichung, it has a market cap of US$230 million, 564 employees and annual sales of $106 million as of 2026.
Adimmune continues to seek expansion its role in the regional pharmaceutical and vaccine industry through international collaborations.
In January 2021, Adimmune Corporation announced a partnership with Sam Chun Dang Pharm to jointly develop an injectable medication used to treat macular disease.
In July 2021, the company announced that its first overseas manufacturing site will be situated in the Special Economic Zone in East Java, Indonesia, aiming to launch clinical trials for its COVID-19 vaccine in Indonesia early 2022.
In August 2021, Adimmune Corporation signed a memorandum of understanding with Becton, Dickinson and Company to strengthen its international pharmaceutical collaboration. Wikipedia
Om Adimmune Corp
Administrerende direktør-
Ansatte564
Grunnlagt1965
Hovedkontor-
SektorHealth Care
Bransje-
Nettstedadimmune.com.tw